Research Fellowship Grant Application supports postdoctoral and junior faculty investigators studying thalassemia and its complications to improve understanding or treatment and benefit patients.
Applications and reference letters are now due February 1, 2027, replacing February 9, 2026. The award period shifts from July 1, 2026–June 30, 2027 to July 1, 2027–June 30, 2028; notifications move from May 2026 to May 2027, and forms and funder acknowledgment details also changed.
Ongoing Clinical Research in Thalassemia Application supports investigators conducting patient-centered clinical studies to address health, quality-of-life, and disease-burden issues in thalassemia.
Clinical Trials in Thalassemia Cell and Gene Therapy Application supports investigators conducting cell and gene therapy trials and related preclinical work to advance a cure for thalassemia.
Early-Career Scientific Research Grants Program supports early-career investigators’ original research in blood banking, transfusion medicine and biotherapies to build data and advance research independence.
The Galactosemia Foundation Research Grant Program funds innovative research to advance scientific understanding and improve treatment of classical galactosemia.
Research Grants - Amyloidosis Foundation support junior scientists' basic biomedical and clinical research on systemic amyloidosis to advance disease knowledge, expedite therapies, and improve patient outcomes.